Imophoron
PrivateLast Round
Seed
Jul 6, 2023
Total Funding Raised
$8.49M
Company Overview
Imophoron is a biotechnology company developing a novel, next-generation nanoparticle platform, ADDomer™, for the development of vaccines to combat infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imophoron Comparables
Compare Imophoron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Uvax Bio, LLC | 81% | |
| Osivax | 76% | |
| Tiba Biotech | 74% | |
Imophoron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 6, 2023 | ||||
| Seed | Oct 7, 2021 | ||||
| Grant | Dec 1, 2017 |
Imophoron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Global Brain Corporation | Seed |
| Spin Up Science | Seed |
| Science Creates Ventures | Seed |
| Octopus Investments | Seed |
| Biotechnology and Biological Sciences Research Council | Grant |
| Octopus Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2023
Raised $3.05M from Octopus Investments, Global Brain, and Science Creates.
- Oct 7, 2021
$5.4M round led by Octopus Ventures and Science Creates Ventures
Imophoron Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imophoron's valuation, stock price, and market status.